EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC-ND 4.0

Somatic Mosaic NLRC4 Variants in Autoinflammatory Diseases: Functional Characterization and Correlation of Mosaicism Levels with Disease Age of Onset and Severity

Farah Diab, Camille Louvrier, Marc Fabre, Christine Lin, Mira Rabbaa, Eman Assrawi, Aphrodite Daskalopoulou, Rahma Mani, Florence Dastot Le Moal, William Piterboth, Marie Legendre, Serge Amselem und 2 weitere

Journal of Clinical Immunology · 2025-12 · 45 (1)

DOI: 10.1007/s10875-025-01907-w ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Clinical Immunology, online erschienen am 08.07.2025. Verfasst von Farah Diab und 13 weiteren Autor:innen. Beteiligte Einrichtung: Maladies génétiques d'expression pédiatrique, Sorbonne Université, INSERM UMR_S933, Hôpital Trousseau, Paris, F-75012, France. Hauptthemen laut MEDLINE: Calcium-Binding Proteins, CARD Signaling Adaptor Proteins, Genetic Variation, Hereditary Autoinflammatory Diseases. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: The European Union's Horizon 2020 research and innovation program, The European Union’s Horizon 2020 research and innovation program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Autoinflammatory diseases (AIDs) are a group of disorders caused by a dysregulation of the innate immune system, among which inflammasomopathies are characterized by recurrent episodes of fever associated with systemic inflammation and organ involvement. Gain-of-function variants in the inflammasome-related gene NLRC4 underlie severe phenotypes such as infantile enterocolitis and macrophage activation syndrome (MAS). While most NLRC4 variants are germline, somatic mosaic variants remain rare, with only three documented cases. In this study, following a targeted deep next-generation sequencing approach, we identified a NLRC4 variant —c.398C>T p.(Thr133Ile)— in a somatic mosaic state (variant allele fraction of 5%) in a 28-year-old patient with recurrent episodes of systemic inflammation without MAS. Functional analyses revealed that this variant, as well as two previously reported NLRC4 mosaic variants, resulted in a gain-of-function effect on NLRC4 inflammasome and NF-κB pathway activation. While relying on data from all reported patients with NLRC4 mosaic variants, we also showed that all mosaic variants cluster near the NLRC4 adenosine-diphosphate binding site and that patients with high levels of mosaicism had earlier and more severe symptoms than those with lower mosaicism levels. Overall, our findings, which unveil a correlation between the percentage of mosaicism and the age of onset and severity of the disease, underline the need to recognize the full spectrum of NLRC4-AIDs, which can often be underdiagnosed, particularly in patients with low mosaicism levels. Such a diagnosis is, however, essential, as targeted treatments —such as anti-IL-1 therapies, which proved highly effective for our patient— can significantly improve patient outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Calcium-Binding ProteinsCARD Signaling Adaptor ProteinsGenetic VariationHereditary Autoinflammatory DiseasesMosaicismMutationAdultHumansMaleAge of OnsetGenetic Predisposition to DiseaseInflammasomesNF-kappa BSeverity of Illness Index

Stichwörter der Autor:innen

Autoinflammatory diseasesInflammasomeMosaic variantNLRC4

Substanzen

Calcium-Binding ProteinsCARD Signaling Adaptor ProteinsInflammasomesNF-kappa BNLRC4 protein, human

Autor:innen und Institutionen

  • Maladies génétiques d'expression pédiatrique, Sorbonne Université, INSERM UMR_S933, Hôpital Trousseau, Paris, F-75012, France.
  • UF de Génétique moléculaire, Assistance Publique-Hôpitaux de Paris, Hôpital Trousseau, Paris, F-75012, France.
  • Service de Médecine interne, Maladies infectieuses et Hématologie, Centre Hospitalier Pierre Oudot, Bourgoin-Jallieu, France.
  • Maladies génétiques d'expression pédiatrique, Sorbonne Université, INSERM UMR_S933, Hôpital Trousseau, Paris, F-75012, France. irina.giurgea@inserm.fr.
  • UF de Génétique moléculaire, Assistance Publique-Hôpitaux de Paris, Hôpital Trousseau, Paris, F-75012, France. irina.giurgea@inserm.fr.

Förderung

  • The European Union's Horizon 2020 research and innovation program
  • The European Union’s Horizon 2020 research and innovation program

Zitieren

APA

Diab, F., Louvrier, C., Fabre, M., Lin, C., Rabbaa, M., Assrawi, E., Daskalopoulou, A., Mani, R., Dastot Le Moal, F., Piterboth, W., Legendre, M., Amselem, S., Karabina, S. A., & Giurgea, I. (2025). Somatic Mosaic NLRC4 Variants in Autoinflammatory Diseases: Functional Characterization and Correlation of Mosaicism Levels with Disease Age of Onset and Severity. Journal of Clinical Immunology, 45(1). https://doi.org/10.1007/s10875-025-01907-w

Vancouver

Diab F, Louvrier C, Fabre M, Lin C, Rabbaa M, Assrawi E, et al. Somatic Mosaic NLRC4 Variants in Autoinflammatory Diseases: Functional Characterization and Correlation of Mosaicism Levels with Disease Age of Onset and Severity. Journal of Clinical Immunology. 2025;45(1). doi:10.1007/s10875-025-01907-w

BibTeX
@article{Diab2025,
  author = {Diab, Farah and Louvrier, Camille and Fabre, Marc and Lin, Christine and Rabbaa, Mira and Assrawi, Eman and Daskalopoulou, Aphrodite and Mani, Rahma and Dastot Le Moal, Florence and Piterboth, William and Legendre, Marie and Amselem, Serge and Karabina, Sonia Athina and Giurgea, Irina},
  title = {Somatic Mosaic NLRC4 Variants in Autoinflammatory Diseases: Functional Characterization and Correlation of Mosaicism Levels with Disease Age of Onset and Severity},
  journal = {Journal of Clinical Immunology},
  year = {2025},
  volume = {45},
  number = {1},
  doi = {10.1007/s10875-025-01907-w}
}
Kostenlos starten →